
[Federal Register Volume 79, Number 177 (Friday, September 12, 2014)]
[Notices]
[Page 54729]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21728]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-1422]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Eye Tracking Study of Direct-to-
Consumer Prescription Drug Advertisement Viewing

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Eye Tracking Study of Direct-to-
Consumer Prescription Drug Advertisement Viewing'' has been approved by 
the Office of Management and Budget (OMB) under the Paperwork Reduction 
Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On June 30, 2014, the Agency submitted a 
proposed collection of information entitled ``Eye Tracking Study of 
Direct-to-Consumer Prescription Drug Advertisement Viewing'' to OMB for 
review and clearance under 44 U.S.C. 3507. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number. 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0772. The approval expires on August 31, 2017. A 
copy of the supporting statement for this information collection is 
available on the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: September 8, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-21728 Filed 9-11-14; 8:45 am]
BILLING CODE 4164-01-P


